6-Hydroxymethylacylfulvene
6-Hydroxymethylacylfulvene, also called irofulven, is an experimental drug studied for treating some cancers. It works by attaching to cancer cells’ DNA, which may help stop their growth. It belongs to a group of medicines called alkylating agents that interfere with cancer cell division. It is not yet a standard treatment but may be available in clinical trials.